| Released | Contributor | Author | Title | Pages | Price |
| 29-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Kindred Healthcare has a current Overall Rating of D (Negative). | 7 |
$25 |
| 28-Nov-2009 | Standard & Poor's STARS Report |
N/A
| Kindred Healthcare | 8 |
$35 |
| 27-Nov-2009 | Validea |
N/A
| Validea Guru Analysis Report for KND. Analysis using Validea's interpretation of the published quantitative strategies of well-known Wall Street experts including Peter Lynch, Warren Buffett, Ben Graham and Ken Fisher, among others. | 0 |
$18 |
| 26-Nov-2009 | ValuEngine, Inc. |
N/A
| ValuEngine Industry Report for HOSPITALS | 18 |
$49 |
| 26-Nov-2009 | New Constructs, LLC |
N/A
| KND: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings | 19 |
$10 |
| 26-Nov-2009 | Pechala's Reports | Lubomir Pechala | KINDRED HEALTHCARE INC (KND=US) - REPORT FOR ACTIVE TRADERS | 4 |
$25 |
| 24-Nov-2009 | Jefferson Research |
N/A
| Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of KINDRED HEALTHCARE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation. | 3 |
$20 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| Hospital & Nursing Home Intelligence Monitor: overall outlook STRONG - 8 new Leaders; 6 new Laggards. | 29 |
$20 |
| 23-Nov-2009 | PriceTarget Research, Inc. |
N/A
| S&P MidCap Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 25 new Laggards. | 65 |
$40 |
| 23-Nov-2009 | Reuters Investment Profile |
N/A
| Kindred Healthcare Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 |
$20 |
1.48% Nasdaq 
Research Reports
